Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment

被引：10
|
作者：
Gonzalez-Garcia, Andres [1 ]
Garcia-Sanchez, Isabel [1 ]
Lopes, Vanessa [1 ]
Munoz Moreno-Arrones, Oscar [1 ]
Tortosa-Cabanas, Marina [1 ]
Elias-Saenz, Isabel [1 ]
Hernandez-Rodriguez, Jose [2 ]
机构：
[1] Univ Alcala, IRYCIS, Hosp Univ Ramon & Cajal, Dept Internal Med,Autoimmune & Rare Dis Unit, Madrid, Spain
[2] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Dept Autoimmune Dis,Clin Unit,Autoinflammatory Di, Barcelona, Spain
来源：
RHEUMATOLOGY | 2020年 / 59卷 / 08期
关键词：
CYTOKINE STORM;
D O I：
10.1093/rheumatology/keaa318
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2171 / 2173
页数：4
相关论文
共 50 条
  • [21] Dexamethasone for treatment of severe COVID-19, a surprise?
    Elsayed, Hany Hasan
    CARDIOTHORACIC SURGEON, 2020, 28 (01):
  • [22] Treatment of severe COVID-19: an evolving paradigm
    McCarthy, Matthew W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (17) : 1887 - 1891
  • [23] A meta analysis on the utility of Anakinra in severe COVID-19 disease
    Hussein, Aliae A. R. Mohamed
    Sayad, Reem
    Abdelshafi, Abdelrahman
    Hammam, Islam Abdelaal
    Kedwany, Ahmed M.
    Elkholy, Shrouk Alaa-eldein
    Ibrahim, Islam H.
    CYTOKINE, 2023, 169
  • [24] Successful treatment of COVID-19 infection in a patient with tracheostomy
    Oz, Mirac
    Gurun Kaya, Aslihan
    Velioglu Yakut, Ovgu
    Gulten, Ezgi
    Talan, Leyla
    Erol, Serhat
    Ciftci, Fatma
    Uzun, Caglar
    Karahan, Zeynep Ceren
    Altintas, Neriman Defne
    Ciledag, Aydin
    Kaya, Akin
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (04): : 444 - 448
  • [25] Successful treatment of patients severely ill with COVID-19
    Bao, Z.
    Gu, B.
    Liu, J.
    Zhu, J.
    Alffenaar, J. W.
    Hu, Y.
    Shen, X.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (06) : 650 - 653
  • [26] Successful treatment of a COVID-19 patient with thrombotic microangiopathy
    Safak, Seda
    Aksoy, Elif
    Dirim, Ahmet Burak
    Demir, Erol
    Garayeva, Nurana
    Oto, Ozgur Akin
    Artan, Ayse Serra
    Yazici, Halil
    Besisik, Sevgi
    Turkmen, Aydin
    CLINICAL KIDNEY JOURNAL, 2021, 14 (04) : 1287 - 1288
  • [27] Successful treatment of a critical COVID-19 patient with tocilizumab
    Tsao, Shih-Ming
    Wang, Jann-Yuan
    Li, Chien-Feng
    Hsieh, Ming-Chang
    Wang, Yao-Tung
    Chan, Kuei-Chuan
    Pan, Hui-Hsien
    Lee, Yuan-Ti
    Huang, Yi-Wen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (05) : 1276 - 1278
  • [28] Severe Pediatric COVID-19 Pneumonia Treated With Adjuvant Anakinra
    Stubbs, Leigh A.
    Szafron, Vibha
    Forbes, Lisa R.
    Musick, Matthew A.
    Gillispie, Amanda E.
    Sauer, Hannah E.
    Smith, Valeria R.
    Fasipe, Titilope A.
    Munoz, Flor M.
    Tejtel, Kristen Sexson
    Silva-Carmona, Manuel
    Vogel, Tiphanie P.
    Muscal, Eyal
    HOSPITAL PEDIATRICS, 2022, 12 (05) : e162 - e170
  • [29] Evaluation of the effects of anakinra treatment on clinic and laboratory results in patients with COVID-19
    Siyer, Ozge
    Aksakal, Berrin
    Basat, Sema
    NORTHERN CLINICS OF ISTANBUL, 2023, 10 (02) : 189 - 196
  • [30] Comparison of Tocilizumab and Anakinra in the Treatment of COVID-19: A Single-Center Experience
    Acat, Murat
    Cavdar, Ozben
    Tezce, Ahmet
    Acat, Bengisu Pinar
    DUZCE MEDICAL JOURNAL, 2022, 24 (02) : 116 - 120
12345